Sight Sciences, Inc. (SGHT)
$8.39-6.47%Close
BUYBEAR · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $456M
- Beta
- 2.45
- P/E (TTM)
- -15.03
- Short % float
- 4.03%
- Days to cover
- 4.1
- SI change
- +13.1%
- 1W
- -1.99%
- 1M
- +3.20%
- vs SPY 1W
- -1.85%
- vs SPY 1M
- +0.69%
Industry peers
FMP comparable companies · ranked by market cap
- ALCSELLAlcon Inc.$31.4BBEARQ 9$64.35-2.10%
- GKOSBUYGlaukos Corporation$9.9BRECOVERYQ 19$168.02-1.50%
- BHCSELLBausch Health Companies Inc.$2.2BRECOVERYQ 2$5.93-0.67%
- OCULSELLOcular Therapeutix, Inc.$1.7BCRISISQ 3$7.56-4.23%
- HROWSELLHarrow Health, Inc.$1.1BCRISISQ 14$29.11-2.99%
- SGPSELLSpyGlass Pharma, Inc. Common Stock$831MQ -1$24.86-3.78%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SGHT?
- LOPJLB’s latest quantitative signal on Sight Sciences, Inc. (SGHT) is BUY in a BEAR regime. Signals are updated daily.
- What market regime is SGHT in?
- Sight Sciences, Inc. (SGHT) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Sight Sciences, Inc. (SGHT) do?
- Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients. Another notable offering is the T…